Cargando…
KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3
Bladder cancer (BC) is among the most common urinary system tumors with a high morbidity and mortality worldwide. Despite advancements being made in the diagnosis and treatment of bladder cancer, targeted therapy remains the most promising treatment, and novel therapeutic targets are urgently requir...
Autores principales: | Zheng, Pengyi, Wu, Kaijie, Gao, Zhongwei, Li, Huibing, Li, Wensheng, Wang, Xiaohui, Shi, Zhenguo, Xiao, Fei, Wang, Kaixuan, Li, Zhijun, Han, Qingjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041479/ https://www.ncbi.nlm.nih.gov/pubmed/33846765 http://dx.doi.org/10.3892/ijmm.2021.4932 |
Ejemplares similares
-
KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3
por: Zheng, Pengyi, et al.
Publicado: (2023) -
NCAPG Promotes the Proliferation of Renal Clear Cell Carcinoma via Mediating with CDK1
por: Li, Huibing, et al.
Publicado: (2022) -
High lncRNA HULC expression is associated with poor prognosis and promotes tumor progression by regulating epithelial-mesenchymal transition in prostate cancer
por: Zheng, Pengyi, et al.
Publicado: (2017) -
KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2021) -
[Retracted] KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2023)